Lactobacillus Rhamnosus GG in the Middle Ear and Adenoid Tonsil
NCT ID: NCT02110732
Last Updated: 2021-06-02
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2011-01-31
2011-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Probiotics on Nasopharyngeal Microbiome of Children With Otitis Media With Effusion
NCT03277820
Probiotic Chewables in Allergic Rhinoconjunctivitis Patients
NCT04898686
A Pilot Trial to Determine the Efficacy of Lactobacillus Rhamnosus for Reducing Colonization by Methicillin-resistant Staphylococcus Aureus (MRSA) (PROSE)
NCT01112995
The Effect of a Probiotic on Upper Respiratory Tract Infections
NCT03636191
Impact in Off-spring of Mothers After Perinatal Daily Intake of a Probiotic
NCT00159523
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lactobacillus rhamnosus GG
Lactobacillus rhamnosus GG 8-9 x 10 -9 pmy 2x2 for 3 weeks
Lactobacillus rhamnosus GG
Crystalline cellulose
Crystalline cellulose
Lactobacillus rhamnosus GG
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lactobacillus rhamnosus GG
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* secretory otitis media
* chronic rhinitis
* recurrent sinusitis
Exclusion Criteria
1 Year
5 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Finnish Institute for Health and Welfare
OTHER_GOV
Helsinki University Central Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anne pitkäranta
Professor/Chief Physician at Hospital District of Helsinki and Uusimaa
References
Explore related publications, articles, or registry entries linked to this study.
Tapiovaara L, Lehtoranta L, Swanljung E, Makivuokko H, Laakso S, Roivainen M, Korpela R, Pitkaranta A. Lactobacillus rhamnosus GG in the middle ear after randomized, double-blind, placebo-controlled oral administration. Int J Pediatr Otorhinolaryngol. 2014 Oct;78(10):1637-41. doi: 10.1016/j.ijporl.2014.07.011. Epub 2014 Jul 18.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HelsinkiUCH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.